Glioblastoma extracellular vesicles influence glial cell hyaluronic acid deposition to promote invasiveness

Koessinger, D. et al. (2023) Glioblastoma extracellular vesicles influence glial cell hyaluronic acid deposition to promote invasiveness. Neuro-Oncology Advances, 5(1), vdad067. (doi: 10.1093/noajnl/vdad067) (PMID:37334166) (PMCID:PMC10276538)

[img] Text
300061.pdf - Published Version
Available under License Creative Commons Attribution.

1MB

Abstract

Background. Infiltration of glioblastoma (GBM) throughout the brain leads to its inevitable recurrence following standard-of-care treatments, such as surgical resection, chemo- and radio-therapy. A deeper understanding of the mechanisms invoked by GMB to infiltrate the brain is needed to develop approaches to contain the disease and reduce recurrence. The aim of this study was to discover mechanisms through which extracellular vesicles (EVs) released by GBM influence the brain microenvironment to facilitate infiltration, and to determine how altered extracellular matrix (ECM) deposition by glial cells might contribute to this. Methods. CRISPR was used to delete genes, previously established to drive carcinoma invasiveness and EV production, from patient-derived primary and GBM cell lines. We purified and characterised EVs released by these cells, assessed their capacity to foster pro-migratory microenvironments in mouse brain slices, and evaluated the contribution made by astrocyte-derived extracellular matrix (ECM) to this. Finally, we determined how CRISPR-mediated deletion of genes, which we had found to control EV-mediated communication between GBM cells and astrocytes, influenced GBM infiltration when orthotopically injected into CD1-nude mice. Results. GBM cells expressing a p53 mutant (p53 273H) with established pro-invasive gain-of-function release EVs containing a sialomucin, podocalyxin (PODXL), which encourages astrocytes to deposit ECM with increased levels of hyaluronic acid (HA). This HA-rich ECM, in turn, promotes migration of GBM cells. Consistently, CRISPR-mediated deletion of PODXL opposes infiltration of GBM in vivo. Conclusions This work describes several key components of an EV-mediated mechanism though which GBM cells educate astrocytes to support infiltration of the surrounding healthy brain tissue. Conclusions. This work describes several key components of an EV-mediated mechanism though which GBM cells educate astrocytes to support infiltration of the surrounding healthy brain tissue.

Item Type:Articles
Additional Information:Funding. This work was funded by Cancer Research UK (A18277), Breast Cancer Now (2019NovPR1268), and the Medical Research Council (MR/P01058X/1). We acknowledge the Cancer Research UK Glasgow Centre (C596/A18076) and the BSU facilities at the Cancer Research UK Beatson Institute (C596/A17196).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Novo, Dr David and Norman, Professor James and Birch, Dr Joanna and Stevenson, Mrs Katrina and Paschke, Dr Peggy and Koessinger, Dr Anna and Zerbst, Désirée and Neilson, Dr Matthew and Peters, Jasmine and Tait, Professor Stephen and Dutton, Ms Louise and Koessinger, Dr Dominik and Chalmers, Professor Anthony
Authors: Koessinger, D., Novo, D., Koessinger, A., Campos, A., Peters, J., Dutton, L., Paschke, P., Zerbst, D., Moore, M., Mitchell, L., Neilson, M., Stevenson, K., Chalmers, A., Tait, S., Birch, J., and Norman, J.
College/School:College of Medical Veterinary and Life Sciences
College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Neuro-Oncology Advances
Publisher:Oxford University Press
ISSN:2632-2498
ISSN (Online):2632-2498
Published Online:27 May 2023
Copyright Holders:Copyright © 2023 The Authors
First Published:First published in Neuro-Oncology Advances 5(1):vdad067
Publisher Policy:Reproduced under a Creative Commons licence

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
304466Evaluation of metabotropic glutamate receptor 3 as a therapeutic target in breast cancer.Iain MacphersonBreast Cancer Now (BRCANNOW)2018NovPR1268SCS - Clinical Research Gartnavel
173591The role of the transfer RNA repertoire in dictating secretory phenotypes during epithelial homeostasisJames NormanMedical Research Council (MRC)MR/P01058X/1SCS - Beatson Institute for Cancer Research
190874CR-UK Centre renewalKaren VousdenCancer Research UK (CRUK)C596/A18076School of Cancer Sciences